SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-20-020373
Filing Date
2020-08-05
Accepted
2020-08-05 16:00:41
Documents
51
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0620_inmunebio.htm 10-Q 369098
2 CERTIFICATIONS f10q0620ex31-1_inmunebio.htm EX-31.1 10542
3 CERTIFICATIONS f10q0620ex31-2_inmunebio.htm EX-31.2 10518
4 CERTIFICATION f10q0620ex32-1_inmunebio.htm EX-32.1 4212
5 CERTIFICATION f10q0620ex32-2_inmunebio.htm EX-32.2 4274
  Complete submission text file 0001213900-20-020373.txt   2750582

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE inmb-20200630.xml EX-101.INS 363972
7 XBRL SCHEMA FILE inmb-20200630.xsd EX-101.SCH 46116
8 XBRL CALCULATION FILE inmb-20200630_cal.xml EX-101.CAL 35562
9 XBRL DEFINITION FILE inmb-20200630_def.xml EX-101.DEF 173148
10 XBRL LABEL FILE inmb-20200630_lab.xml EX-101.LAB 302330
11 XBRL PRESENTATION FILE inmb-20200630_pre.xml EX-101.PRE 241449
Mailing Address 1200 PROSPECT STREET SUITE 525 LA JOLLA CA 92037
Business Address 1200 PROSPECT STREET SUITE 525 LA JOLLA CA 92037 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

IRS No.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38793 | Film No.: 201077122
SIC: 2836 Biological Products, (No Diagnostic Substances)